Undisclosed Target
Showing 1 - 25 of 8,714
Diastolic Heart Failure Trial in Canada, United States (Sitaxsentan sodium, Placebo)
Completed
- Diastolic Heart Failure
- Sitexsentin sodium
- Placebo
-
Birmingham, Alabama
- +51 more
Dec 8, 2022
Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)
Terminated
- Renal Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Saint Louis, Missouri
- +11 more
Dec 15, 2022
Nasopharyngeal Carcinoma, De-escaltion Therapy Trial in Guangzhou (Reduced-target resection, Full-target resection, Adjuvant
Recruiting
- Nasopharyngeal Carcinoma
- De-escaltion Therapy
- Reduced-target resection
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 25, 2023
Dialysis, End Stage Renal Disease, Hemodialysis Trial in Kingston (Twice per week dialysis)
Recruiting
- Dialysis
- +2 more
- Twice per week dialysis
-
Kingston, Ontario, CanadaKingston Health Sciences Centre (KHSC)
May 26, 2022
Acute Kidney Injury, Cirrhosis, Portal Hypertension Trial in San Francisco (MAP-Target Algorithm)
Not yet recruiting
- Acute Kidney Injury
- +5 more
- MAP-Target Algorithm
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 14, 2023
Hand-Foot Syndrome Trial (acupuncture, laser acupuncture, Sham-laser acupuncture)
Not yet recruiting
- Hand-Foot Syndrome
- acupuncture
- +2 more
- (no location specified)
Jul 9, 2023
An Observational Study of Patients With Chronic Liver Disease
Not yet recruiting
- Chronic Liver Disease
- Cirrhosis
- Observational
- (no location specified)
Feb 15, 2023
Coronary Artery Disease, Ischemic Heart Disease Trial in Suwon (Procedure: planed 2-stent strategy, Procedure: provisional
Recruiting
- Coronary Artery Disease
- Ischemic Heart Disease
- Procedure: planed 2-stent strategy
- Procedure: provisional 1-stent plus DEB strategy
-
Suwon, Gyeonggi-do, Korea, Republic ofSt. Vincent's Hospital , the Catholic University
Aug 17, 2023
Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)
Recruiting
- Drug-eluting Stent
- Coronary Artery Disease
- Genoss® DES system, Genoss® Osfit system
-
Suwon, Korea, Republic ofAjou University Hospital
Sep 27, 2023
Rheumatoid Arthritis Trial (Treatment target DAS28CRP-LDA, Treatment target SDAI-remission)
Not yet recruiting
- Rheumatoid Arthritis
- Treatment target DAS28CRP-LDA
- Treatment target SDAI-remission
- (no location specified)
Sep 13, 2023
In-stent Restenosis Trial in Yongin (Genoss® DCB)
Enrolling by invitation
- In-stent Restenosis
- Genoss® DCB
-
Yongin, Korea, Republic ofYongin Severance Hospital
Dec 11, 2022
Gastroscopy Trial in Chengdu (other, procedure, drug)
Completed
- Gastroscopy
- Bispectral index
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital
Mar 15, 2023
Pib Specific Phage, Intractable Constipation Trial in Shanghai (phage)
Recruiting
- Pib Specific Phage
- Intractable Constipation
- phage
-
Shanghai, ChinaShanghai Tenth People's Hospital
Jul 25, 2023
Dyslipidemias Trial in Korea, Republic of (Atorvastatin)
Completed
- Dyslipidemias
-
Daegu, Korea, Korea, Republic of
- +19 more
Feb 17, 2021
Cutaneous Neurofibroma, Neurofibromatosis 1 Trial in United States (NFX-179 gel, Vehicle gel)
Recruiting
- Cutaneous Neurofibroma
- Neurofibromatosis 1
- NFX-179 gel
- Vehicle gel
-
Little Rock, Arkansas
- +22 more
Jan 18, 2023
NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Crizotinib - Usual
- Crizotinib - Study
-
Rockville, MarylandMedicine Invention Design, Inc. - IORG0007849
Oct 5, 2023
OCD Trial in Paris, Poitiers (rTMS Treatment)
Recruiting
- Obsessive-Compulsive Disorder
- rTMS Treatment
-
Paris, France
- +1 more
Jan 18, 2023
NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)
Not yet recruiting
- Non-small Cell Lung Cancer
- Crizotinib - Usual
- Crizotinib - Study
-
Rockville, MarylandMedicine Invention Design, Inc. - IORG0007849
Aug 15, 2023
Schizophrenia Trial in Gaithersburg (Luvadaxistat, Matching Placebo)
Completed
- Schizophrenia
- Luvadaxistat
- Matching Placebo
-
Gaithersburg, MarylandCBH Health, LLC
Dec 7, 2021
Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
- Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
- (no location specified)
Mar 14, 2023
ScanNav Anatomy PNB FDA Data Collection Plan
Not yet recruiting
- Ultrasound Recordings
- Ultrasound scans
- (no location specified)
Jul 19, 2023
Rehabilitation Trial (Immediate WBAT, No Intervention: Delayed WBAT)
Not yet recruiting
- Rehabilitation
- Immediate WBAT
- No Intervention: Delayed WBAT
- (no location specified)
Jan 19, 2023